# US 2010/0063393 A1 · Method for Improved Ultrasonic Detection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0063393 A1
- Document ID: US20100063393A1
- Status: Published application
- Kind: A1
- Application number: 12/227,697
- Filed: 2007-05-25
- Published: 2010-03-11
- Earliest claimed: 2006-05-26
- Assignees: Queen's University at Kingston
- Inventors: Mehdi Moradi; Purang Abolmaesumi; Parvin Mousavi; Eric Sauerbrei; Robert Siemens; Phillip Isotalo
- Web page: https://patentgrep.com/patent/US20100063393A1

## CPC

- G01S 7/52036: {using analysis of echo signal for target characterisation}
- A61B 8/0833: {involving detecting or locating foreign bodies or organic structures}
- G01S 15/8977: {using special techniques for image reconstruction, e.g. FFT, geometrical transformations, spatial deconvolution, time deconvolution}
- G01S: RADIO DIRECTION-FINDING; RADIO NAVIGATION; DETERMINING DISTANCE OR VELOCITY BY USE OF RADIO WAVES; LOCATING OR PRESENCE-DETECTING BY USE OF THE REFLECTION OR RERADIATION OF RADIO WAVES; ANALOGOUS ARRANGEMENTS USING OTHER WAVES
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

This invention relates to a method of analyzing an ultrasound signal. The method comprises obtaining a time series of sequential data frames associated with an ultrasound signal reflected from and/or backscattered from a fixed location of a material under investigation, each data frame comprising a plurality of samples of the ultrasound signal, and subjecting to an analysis a sequence of one or more samples of the ultrasound signal, or a sequence of at least one parameter derived from one or more samples of the ultrasound signal, wherein a result of the analysis is related to one or properties or characteristics of the material. In one embodiment the method may be used for detecting, diagnosing, and/or assessing cancer and/or abnormalities in biological tissue.

## Claims

### Claim 1

A method for analyzing an ultrasound signal reflected from and/or backscattered from a material, comprising:
obtaining a time series of sequential data frames associated with the ultrasound signal from a fixed location of the material, each data frame comprising a plurality of samples of the ultrasound signal, and
subjecting to an analysis:
(i) a sequence of one or more samples of the ultrasound signal, or
(ii) a sequence of at least one parameter derived from one or more samples of the ultrasound signal;
wherein a result of the analysis is indicative of one or more physical properties of the material.

### Claim 2 (depends on 1)

The method of claim 1, wherein the data is derived from a radio frequency (RF) ultrasound signal.

### Claim 3 (depends on 1)

The method of claim 1, wherein the data is derived from a processed ultrasound signal.

### Claim 4 (depends on 1)

The method of claim 1, wherein the data is derived from an ultrasound signal selected from an A-mode, B-mode, M-mode, Doppler, or 3-D ultrasound signal.

### Claim 5 (depends on 1)

The method of claim 1, wherein the analysis is at least one selected from:
(i) an analysis with respect to time, frequency, amplitude, or a combination thereof,
(ii) a statistical analysis,
(iii) a stochastic analysis,
(iv) a fractal analysis;
(v) a wavelet analysis;
(vi) a spectral analysis;
(vii) array processing; and
(viii) a combination of two or more of the above.

### Claim 6 (depends on 5)

The method of claim 5, wherein the analysis is fractal analysis.

### Claim 7 (depends on 1)

The method of claim 1, wherein the result of the analysis is indicative of the physical property of the material being normal or abnormal.

### Claim 8 (depends on 1)

The method of claim 1, wherein the result of the analysis is a probability map or a probability score.

### Claim 9 (depends on 7)

The method of claim 7, wherein the result of the analysis is indicative of severity of the abnormality in the material.

### Claim 10 (depends on 7)

The method of claim 7, wherein the result of the analysis describes the presence of the abnormality in the material.

### Claim 11 (depends on 1)

The method of claim 1, wherein the material is biological tissue.

### Claim 12 (depends on 11)

The method of claim 11, wherein the biological tissue is human biological tissue.

### Claim 13 (depends on 10)

The method of claim 10, wherein the material is biological tissue and the abnormality in the biological tissue is cancer.

### Claim 14 (depends on 13)

The method of claim 13, wherein the cancer is associated with at least one of female genital tract (ovary, fallopian tube, uterus, cervix and vagina), male genital tract (prostate and testis), urinary tract (kidney, ureter and prostate gland), mediastinum and heart, gastrointestinal tract (small and large intestines, liver, pancreas, gallbladder and biliary system), breast, skin, nervous system, endocrine organs (thyroid gland, adrenal gland), head and neck region, lymph nodes, soft tissue, respiratory system (including lung), and combinations thereof.

### Claim 15 (depends on 14)

The method of claim 14, wherein the cancer is prostate cancer.

### Claim 16 (depends on 10)

The method of claim 10, wherein the material is biological tissue and the abnormality in the biological tissue is selected from benign tumour, infection, abscess, necrosis, infarct, and combinations thereof.

### Claim 17 (depends on 2)

The method of claim 2, wherein the analysis comprises subjecting the RF time series data to a discrete Fourier transform.

### Claim 18 (depends on 17)

The method of claim 17, wherein the at least one parameter is selected from:
(i) average of magnitudes of coefficients of the discrete Fourier transform of the RF time series in a low frequency portion of the transformation;
(ii) average of magnitudes of coefficients of the discrete Fourier transform of the RF time series in a mid-low frequency portion of the transformation;
(iii) average of magnitudes of coefficients of the discrete Fourier transform of the RF time series in a mid-high frequency portion of the transformation;
(iv) average of magnitudes of coefficients of the discrete Fourier transform of the RF time series in a high frequency portion of the transformation;
(v) intercept of a line fitted to magnitudes of coefficients of the discrete Fourier transform of the RF time series plotted versus normalized frequency; and
(vi) slope of a line fitted to magnitudes of coefficients of the discrete Fourier transform of the RF time series plotted versus normalized frequency.

### Claim 19

A method for detecting, diagnosing, and/or assessing cancer, comprising:
obtaining a time series of sequential data frames associated with an ultrasound signal reflected from and/or backscattered from a fixed location of a biological tissue, each data frame comprising a plurality of samples of the ultrasound signal, and
subjecting to an analysis:
(i) a sequence of one or more samples of the ultrasound signal, or
(ii) a sequence of at least one parameter derived from one or more samples of the ultrasound signal;
wherein a result of the analysis is related to the detection, diagnosis, and/or assessment of cancer in the biological tissue.

### Claim 20 (depends on 19)

The method of claim 19, wherein the data is derived from a RF ultrasound signal.

### Claim 21 (depends on 19)

The method of claim 19, wherein the data is derived from a processed ultrasound signal.

### Claim 22 (depends on 19)

The method of claim 19, wherein the analysis is at least one selected from:
(i) an analysis with respect to time, frequency, amplitude, or a combination thereof,
(ii) a statistical analysis,
(iii) a stochastic analysis,
(iv) a fractal analysis;
(v) a wavelet analysis;
(vi) a spectral analysis;
(vii) array processing; and
(viii) a combination of two or more of the above.

### Claim 23 (depends on 22)

The method of claim 22, wherein the analysis is fractal analysis.

### Claim 24 (depends on 22)

The method of claim 22, wherein the cancer is associated with at least one of female genital tract (ovary, fallopian tube, uterus, cervix and vagina), male genital tract (prostate and testis), urinary tract (kidney, ureter and prostate gland), mediastinum and heart, gastrointestinal tract (small and large intestines, liver, pancreas, gallbladder and biliary system), breast, skin, nervous system, endocrine organs (thyroid gland, adrenal gland), head and neck region, lymph nodes, soft tissue, respiratory system (including lung), and combinations thereof.

### Claim 25 (depends on 22)

The method of claim 22, wherein the cancer is prostate cancer.

### Claim 26

Programmed media for use with a computer and with an ultrasound signal, the programmed media comprising:
a computer program stored on storage media compatible with the computer, the computer program containing instructions to direct the computer to perform one or more of:
obtain a time series of sequential data frames associated with the ultrasound signal from a fixed location of the material, each data frame comprising a plurality of samples of the ultrasound signal;
subject to an analysis:
(i) a sequence of one or more samples of the ultrasound signal, or
(ii) a sequence of at least one parameter derived from one or more samples of the ultrasound signal;
determine one or more properties of the material based on a result of the analysis, and
output an indication of the one or more properties.

### Claim 27 (depends on 26)

The programmed media of claim 26, wherein the computer program further directs the computer to:
accept data relating to known properties of the same material, or complementary data from subsequent analysis conducted on the same material; and
update the result of the analysis based on a comparison to the data relating to known properties of the same material and/or the complementary data.

### Claim 28 (depends on 26, 27)

A system for determining one or more properties of a material, comprising:
a computer;
the programmed media of claim 26 or 27; and
an ultrasound device for generating an ultrasound signal from the material.
